IPI59: An Actionable Biomarker to Improve Treatment Response in Serous Ovarian Carcinoma Patients.
Choi J, Ye S, Eng KH, Korthauer K, Bradley WH, Rader JS, Kendziorski C. IPI59: An Actionable Biomarker to Improve Treatment Response in Serous Ovarian Carcinoma Patients. Stat Biosci. 2017 Jun; 9(1):1-12.